Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther. 2003 Oct; 74(4):388-400.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.